Grants and Contributions:
Title:
Commercializing new SPR and HDX antibody characterization services through innovative upselling and cross-selling marketing and sales techniques
Agreement Number:
1002700
Agreement Value:
$72,689.00
Agreement Date:
Jan 2, 2023 - Jun 30, 2023
Description:
Rapid Novor is expanding beyond its antibody sequencing work and offering new services for in-depth antibody characterization through HDX epitope mapping and SPR kinetic analysis. The client knows how clients interact with its sequencing services and need to learn how to conduct value-added marketing and sales to commercialize its new antibody characterization services. The client will learn and implement new upselling and cross-selling marketing and sales strategies to increase market awareness and sales opportunities for its new SPR and HDX services.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Kitchener, Ontario, CA N2G 4X8
Reference Number:
172-2022-2023-Q4-1002700
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
804554392
Recipient Type:
For-profit organization
Recipient's Legal Name:
Rapid Novor Inc.
Federal Riding Name:
Kitchener Centre
Federal Riding Number:
35045
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171